FactorPlus — The Helixate® FS Free Hemophilia A Treatment Trial Program

Get connected to treatment that meets a patient’s unique needs with FactorPlus

With FactorPlus — the Helixate FS free trial program — patients can try out a recombinant FVIII treatment for hemophilia A at no cost.

  • When a patient signs up for FactorPlus, he or she is eligible to receive 6 doses, or up to 20,000 IU, of Helixate FS
  • Helixate FS is an effective and safe recombinant FVIII hemophilia A treatment with a wide range of dosages and concentrations
    • The Helixate FS 3000 IU dosage strength makes it possible for some patients to infuse without using multiple vials during major bleeding episodes
  • The FactorPlus Welcome Kit provides a comprehensive overview of hemophilia A and its treatment

Use FactorPlus to see if Helixate FS is the right choice.

Three easy steps to enroll in FactorPlus today

Healthcare professionals will enroll patients in the FactorPlus so that they can begin their free trial of Helixate FS. Here's how:

  1. Patients can bring the trial product request form to their next doctor's appointment.
  2. Patients can share the form with their doctor and discuss whether Helixate FS is the right hemophilia A treatment for them and their loved one.
  3. Patients should ask their doctor to complete the form and send it in for processing

Next: Coding and Reimbursement»

Important Safety Information

You should not use Helixate FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Helixate FS.

Tell your healthcare provider if you have been told you have heart disease or are at risk for heart disease.

You could have an allergic reaction to Helixate FS. Call your healthcare provider right away and stop treatment if you get rash or hives, itching, tightness of the chest or throat, difficulty breathing, light-headed, dizziness, nausea or a decrease in blood pressure.

Your body can make antibodies, called "inhibitors," against Helixate FS, which may stop Helixate FS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to factor VIII.

Other common side effects of Helixate FS are local injection-site reactions (pain, swelling, irritation at infusion site) and infections from implanted injection device. Tell your healthcare provider about any side effect that bothers you or does not go away.

Call your healthcare provider right away if bleeding is not controlled after using Helixate FS.


Helixate FS, Antihemophilic Factor (Recombinant), is medicine used to replace the clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

Helixate FS is used to treat and control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Helixate FS when you have surgery. Helixate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis), and can reduce the risk of joint damage in children without preexisting joint damage when used regularly.

Helixate FS is not used to treat von Willebrand disease.

Please see the full Prescribing Information for HELIXATE FS, including approved patient labeling.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.